Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management.


Journal

Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637

Informations de publication

Date de publication:
06 11 2021
Historique:
received: 20 09 2021
accepted: 25 10 2021
entrez: 6 11 2021
pubmed: 7 11 2021
medline: 18 11 2021
Statut: epublish

Résumé

Type 2 diabetes is one of the most relevant risk factors for heart failure, the prevalence of which is increasing worldwide. The aim of the review is to highlight the current perspectives of the pathophysiology of heart failure as it pertains to type 2 diabetes. This review summarizes the proposed mechanistic bases, explaining the myocardial damage induced by diabetes-related stressors and other risk factors, i.e., cardiomyopathy in type 2 diabetes. We highlight the complex pathology of individuals with type 2 diabetes, including the relationship with chronic kidney disease, metabolic alterations, and heart failure. We also discuss the current criteria used for heart failure diagnosis and the gold standard screening tools for individuals with type 2 diabetes. Currently approved pharmacological therapies with primary use in type 2 diabetes and heart failure, and the treatment-guiding role of NT-proBNP are also presented. Finally, the influence of the presence of type 2 diabetes as well as heart failure on COVID-19 severity is briefly discussed.

Identifiants

pubmed: 34740359
doi: 10.1186/s12933-021-01408-1
pii: 10.1186/s12933-021-01408-1
pmc: PMC8571004
doi:

Substances chimiques

Biomarkers 0
Glycated Hemoglobin A 0
Peptide Fragments 0
hemoglobin A1c protein, human 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

218

Subventions

Organisme : Roche Diagnostics International Ltd.
ID : Roche Diagnostics International Ltd.

Informations de copyright

© 2021. The Author(s).

Références

Curr Hypertens Rep. 2011 Apr;13(2):142-8
pubmed: 21298579
BMJ. 2016 Feb 17;352:i610
pubmed: 26888822
Eur J Heart Fail. 2017 Oct;19(10):1310-1320
pubmed: 28639369
Diabetes Obes Metab. 2021 Nov;23(11):2476-2483
pubmed: 34227220
Hellenic J Cardiol. 2017 Sep - Oct;58(5):342-347
pubmed: 28089648
Ther Adv Chronic Dis. 2020 Jun 10;11:2040622320933108
pubmed: 32566117
J Card Fail. 2010 Mar;16(3):200-6
pubmed: 20206893
Arq Bras Cardiol. 2016 Jan;106(1):62-9
pubmed: 26647721
Med Clin North Am. 2004 Sep;88(5):1209-35
pubmed: 15331314
Int J Cardiol. 2015;187:651-7
pubmed: 25880403
Circulation. 2013 Oct 15;128(16):1810-52
pubmed: 23741057
Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1167
pubmed: 27894487
EClinicalMedicine. 2021 Feb 04;32:100739
pubmed: 33688855
JAMA. 2013 Jul 3;310(1):66-74
pubmed: 23821090
Int J Mol Sci. 2018 Sep 21;19(10):
pubmed: 30248910
Diabetes Care. 2017 Sep;40(9):1203-1209
pubmed: 28684396
N Engl J Med. 2019 Jan 24;380(4):347-357
pubmed: 30415602
Diabetologia. 2021 Apr;64(4):778-794
pubmed: 33599800
Diabetologia. 2006 Oct;49(10):2256-62
pubmed: 16937127
Cardiovasc Diabetol. 2019 Jan 10;18(1):3
pubmed: 30630489
Lancet. 2015 May 23;385(9982):2067-76
pubmed: 25765696
Eur J Heart Fail. 2017 Feb;19(2):167-176
pubmed: 27766748
Eur J Heart Fail. 2018 Aug;20(8):1230-1239
pubmed: 29431256
Cardiovasc Diabetol. 2020 May 2;19(1):49
pubmed: 32359358
Am J Med. 2006 Jan;119(1):70.e23-30
pubmed: 16431191
Eur J Clin Invest. 2011 Dec;41(12):1292-8
pubmed: 21615391
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Lancet. 2009 Aug 15;374(9689):506-8
pubmed: 19683628
Endocrinol Diabetes Metab. 2021 Apr;4(2):e00218
pubmed: 33614986
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur Heart J. 2012 Jul;33(14):1750-7
pubmed: 21821849
Heart. 2016 Oct 1;102(19):1544-51
pubmed: 27226327
Diabetes Care. 2020 Jul;43(7):1427-1432
pubmed: 32409501
Circulation. 2015 Sep 8;132(10):923-31
pubmed: 26152709
BMJ. 2019 Feb 13;364:l223
pubmed: 30760447
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
Front Endocrinol (Lausanne). 2020 Oct 02;11:569250
pubmed: 33133017
J Am Coll Cardiol. 2020 Nov 3;76(18):2076-2085
pubmed: 33121714
Heart. 2015 Jul;101(13):1061-6
pubmed: 25935767
JACC Heart Fail. 2020 May;8(5):372-381
pubmed: 32241619
J Am Soc Nephrol. 2009 Aug;20(8):1813-21
pubmed: 19443635
Cardiovasc Diabetol. 2021 Aug 19;20(1):170
pubmed: 34412646
Diabetes Obes Metab. 2021 Aug;23(8):1746-1753
pubmed: 33769672
Cardiovasc Diabetol. 2016 Nov 3;15(1):151
pubmed: 27809845
Lancet Diabetes Endocrinol. 2019 Mar;7(3):221-230
pubmed: 30115599
Prim Care Diabetes. 2021 Apr;15(2):332-339
pubmed: 33277201
Cureus. 2020 Oct 22;12(10):e11100
pubmed: 33240696
N Engl J Med. 2016 Nov 10;375(19):1834-1844
pubmed: 27633186
Cardiovasc Diabetol. 2021 Sep 8;20(1):180
pubmed: 34496864
JAMA Cardiol. 2021 Feb 1;6(2):148-158
pubmed: 33031522
Eur J Heart Fail. 2017 Jan;19(1):69-77
pubmed: 27790809
Circ Heart Fail. 2016 Jan;9(1):
pubmed: 26754626
Front Cell Dev Biol. 2021 Sep 27;9:750382
pubmed: 34646830
Circ Res. 2018 Feb 16;122(4):624-638
pubmed: 29449364
N Engl J Med. 2019 Oct 24;381(17):1609-1620
pubmed: 31475794
Int J Biol Sci. 2020 Jan 14;16(5):730-738
pubmed: 32071544
Lupus. 2013 Jan;22(1):26-33
pubmed: 23060481
Eur Heart J. 2008 Jun;29(11):1377-85
pubmed: 18413309
Eur Heart J. 2018 Aug 1;39(29):2746-2748
pubmed: 29893842
J Cardiovasc Thorac Res. 2011;3(2):57-61
pubmed: 24250954
Diabetes Metab. 2021 Sep;47(5):101249
pubmed: 33744399
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
Annu Rev Med. 2004;55:373-94
pubmed: 14746527
Circulation. 2014 Oct 28;130(18):1579-88
pubmed: 25189213
N Engl J Med. 2013 Oct 3;369(14):1317-26
pubmed: 23992601
JAMA. 2016 Aug 2;316(5):500-8
pubmed: 27483064
Med J Aust. 2020 Oct;213(8):374-379
pubmed: 32959366
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
J Clin Hypertens (Greenwich). 2009 Dec;11(12):761-5
pubmed: 20021538
Ther Adv Chronic Dis. 2020 Jan 28;11:2040622320901990
pubmed: 32064070
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Am J Cardiol. 2009 Jan 1;103(1):88-92
pubmed: 19101236
Circ Heart Fail. 2011 Jan;4(1):36-43
pubmed: 21071547
Atherosclerosis. 2010 Aug;211(2):596-600
pubmed: 20307881
Circ Heart Fail. 2020 Sep;13(9):e007054
pubmed: 32842761
Heart Fail Clin. 2012 Oct;8(4):633-41
pubmed: 22999245
Diabetes Res Clin Pract. 2021 May;175:108794
pubmed: 33831494
J Card Fail. 2021 Mar 1;:
pubmed: 33663906
BMC Cardiovasc Disord. 2016 Jan 29;16:28
pubmed: 26822790
J Clin Hypertens (Greenwich). 2007 Dec;9(12):956-63
pubmed: 18046102
Lancet. 2020 Sep 19;396(10254):819-829
pubmed: 32877652
Circ Heart Fail. 2013 Mar;6(2):279-86
pubmed: 23271790
Eur J Heart Fail. 2013 Dec;15(12):1350-62
pubmed: 23845797
J Am Coll Cardiol. 2013 Oct 8;62(15):1365-72
pubmed: 23810874
Cardiology. 2014;129(2):84-92
pubmed: 25138610
Adv Med Sci. 2013;58(2):362-8
pubmed: 24327531
Diabetes Care. 2021 Jan;44(Suppl 1):S125-S150
pubmed: 33298421
Eur J Cardiovasc Nurs. 2005 Sep;4(3):198-206
pubmed: 15916924
Eur J Heart Fail. 2018 May;20(5):853-872
pubmed: 29520964
Int J Mol Sci. 2019 Apr 12;20(8):
pubmed: 31013779
Oxid Med Cell Longev. 2020 May 06;2020:2563508
pubmed: 32454934
Am J Cardiovasc Drugs. 2017 Apr;17(2):143-155
pubmed: 27873238
Diabetes Res Clin Pract. 2020 Apr;162:108137
pubmed: 32259611
Lancet Diabetes Endocrinol. 2019 Oct;7(10):776-785
pubmed: 31422062
Br J Clin Pharmacol. 2020 Jul;86(7):1346-1356
pubmed: 32068914
JAMA Cardiol. 2021 Jun 1;6(6):678-689
pubmed: 33787831
J Card Fail. 2005 Oct;11(8):602-6
pubmed: 16230263
Lancet. 2018 Feb 10;391(10120):518-519
pubmed: 29174291
N Engl J Med. 2021 Jan 14;384(2):117-128
pubmed: 33200892
Cardiovasc Diabetol. 2021 Sep 14;20(1):186
pubmed: 34521417
Circulation. 2014 Oct 14;130(16):1374-82
pubmed: 25149362
Circulation. 2003 Mar 11;107(9):1291-6
pubmed: 12628950
J Am Coll Cardiol. 2018 May 22;71(20):2360-2372
pubmed: 29773163
N Engl J Med. 2020 Oct 8;383(15):1425-1435
pubmed: 32966714
N Engl J Med. 2016 Jul 28;375(4):311-22
pubmed: 27295427
JACC Heart Fail. 2020 May;8(5):401-411
pubmed: 32171759
Circulation. 2020 Dec 8;142(23):2205-2215
pubmed: 33026243
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Diabetes Care. 2020 Feb;43(2):487-493
pubmed: 31857443
Eur J Heart Fail. 2019 Jan;21(1):40-49
pubmed: 30537261
Eur J Heart Fail. 2020 Apr;22(4):584-603
pubmed: 31908120
Circ Heart Fail. 2021 Mar;14(3):e007048
pubmed: 33663235
Circulation. 2017 Aug 8;136(6):e137-e161
pubmed: 28455343
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015
N Engl J Med. 2015 Dec 3;373(23):2247-57
pubmed: 26630143
Endocr J. 2014;61(4):329-34
pubmed: 24430727
Lancet Diabetes Endocrinol. 2017 May;5(5):333-340
pubmed: 28330649
Curr Opin Pharmacol. 2020 Oct;54:82-90
pubmed: 32980777
Heart. 2007 Feb;93(2):155-8
pubmed: 16387829
Diabetes Care. 2020 Feb;43(2):426-432
pubmed: 31727686
Circulation. 2009 Apr 14;119(14):e391-479
pubmed: 19324966
Eur Heart J. 2016 Jul 14;37(27):2105-14
pubmed: 27130705
Exp Mol Med. 2019 Dec 19;51(12):1-9
pubmed: 31857581
Can J Cardiol. 2020 May;36(5):671-682
pubmed: 32389340
Circ Res. 2016 May 27;118(11):1830-43
pubmed: 27230644
Int J Endocrinol. 2015;2015:743503
pubmed: 26074964
Diabetes Obes Metab. 2020 Sep;22(9):1607-1618
pubmed: 32363737
N Engl J Med. 2015 Jul 16;373(3):232-42
pubmed: 26052984
BMJ. 2020 May 7;369:m1184
pubmed: 32381490
N Engl J Med. 2018 Aug 16;379(7):633-644
pubmed: 30110583
Cells. 2020 Jan 18;9(1):
pubmed: 31963679
J Pharm Pharm Sci. 2020;23:396-405
pubmed: 33086028
Am J Med. 2001 May 7;110 Suppl 7A:37S-46S
pubmed: 11334774
Diabetes Care. 2007 Nov;30(11):2773-8
pubmed: 17666462
Circ Res. 2019 Jan 4;124(1):121-141
pubmed: 30605420
Am J Hypertens. 2004 Oct;17(10):986-93
pubmed: 15485765
Curr Heart Fail Rep. 2013 Dec;10(4):401-10
pubmed: 24078336
BMJ. 2007 Sep 8;335(7618):508-12
pubmed: 17823192
Am J Clin Nutr. 2006 Jun;83(6):1248-51
pubmed: 16762931
J Diabetes Sci Technol. 2015 Jul 31;10(1):131-6
pubmed: 26232372
J Am Coll Cardiol. 2016 Dec 6;68(22):2425-2436
pubmed: 27908347
Ther Adv Chronic Dis. 2020 Jan 20;11:2040622320901660
pubmed: 32010437
Nat Rev Cardiol. 2022 Feb;19(2):100-116
pubmed: 34489589
ESC Heart Fail. 2018 Dec;5(6):1008-1016
pubmed: 30211480
Cardiovasc Drugs Ther. 2017 Dec;31(5-6):545-549
pubmed: 28948430
J Am Soc Nephrol. 2006 Aug;17(8):2106-11
pubmed: 16825333
Eur Heart J. 2008 Sep;29(18):2259-64
pubmed: 18650200
N Engl J Med. 2006 Jul 20;355(3):251-9
pubmed: 16855265
Eur J Heart Fail. 2020 Aug;22(8):1342-1356
pubmed: 32483830
Circulation. 2018 Jan 16;137(3):286-297
pubmed: 29335288
Sci Rep. 2018 Jan 17;8(1):926
pubmed: 29343820
JACC Heart Fail. 2018 Aug;6(8):678-685
pubmed: 30007560

Auteurs

Antonio Ceriello (A)

IRCCS MultiMedica, Via Gaudenzio Fantoli, 16/15, 20138, Milan, Italy. antonio.ceriello@hotmail.it.

Doina Catrinoiu (D)

Faculty of Medicine, Clinical Center of Diabetes, Nutrition and Metabolic Diseases, Ovidius University of Constanta, Constanta, Romania.

Chanchal Chandramouli (C)

Duke-NUS Medical School, Singapore, Singapore.
National Heart Research Institute, National Heart Centre, Singapore, Singapore.

Francesco Cosentino (F)

Unit of Cardiology, Karolinska Institute, Karolinska University Hospital Solna, Stockholm, Sweden.

Annique Cornelia Dombrowsky (AC)

Sciarc GmbH, Baierbrunn, Germany.

Baruch Itzhak (B)

Clalit Health Services and Technion Faculty of Medicine, Haifa, Israel.

Nebojsa Malić Lalic (NM)

School of Medicine, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University of Belgrade, Belgrade, Serbia.

Francesco Prattichizzo (F)

IRCCS MultiMedica, Via Gaudenzio Fantoli, 16/15, 20138, Milan, Italy.

Oliver Schnell (O)

Forschergruppe Diabetes e. V. at Helmholtz Centre Munich GmbH, Munich, Germany.

Petar M Seferović (PM)

School of Medicine, University of Belgrade, Belgrade University Medical Center, Belgrade, Serbia.

Paul Valensi (P)

Unit of Endocrinology, Diabetology, Nutrition, Jean Verdier Hospital, AP-HP, CRNH-IdF, CINFO, Paris 13 University, Bondy, France.

Eberhard Standl (E)

Forschergruppe Diabetes e. V. at Helmholtz Centre Munich GmbH, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH